A previous study by Dinkins et al. demonstrated that reduction of EVs in vivo by inhibition of ceramide production led to decreased amyloid plaque deposition and amelioration of the neurocognitive effects seen in an AD mouse model expressing a similar mutant APP [27]. Here, APP is linked to amyloidosis.